Related Articles

Here You Can Read About A New Focus on Hepatitis

  The White House’s budget request to Congress included an $11 billion ask to tackle the spread of the hepatitis C virus (HCV) over the next five years.  Though it’s not a crisis that’s well-known or understood, public health efforts in the last 10 years have made strides toward prevention and treatment.  Direct-acting antivirals developed […]
The post Here You Can Read About A New Focus on Hepatitis appeared first on Pennsylvania Office of Rural Health.

Join the VIVA-MIND Study of an Oral Drug for Alzheimer’s!

Researchers at The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio are recruiting participants for the VIVA-MIND study to learn whether a new drug therapy for Alzheimer’s disease can help people experiencing mild memory problems.  Volunteers ages 50 to 89 with a diagnosis of mild cognitive impairment or probable mild …
The post Join the VIVA-MIND Study of an Oral Drug for Alzheimer’s! appeared first on Salud America.